Personalized medicine has largely been enabled by the integration of genomic and other data
with electronic health records (EHRs) in the United States and elsewhere. Increased EHR …

Clinical genetic testing began over 30 years ago with the availability of mutation detection for
sickle cell disease diagnosis. Since then, the field has dramatically transformed to include …

Background Elucidation of the genetic factors underlying chronic liver disease may reveal
new therapeutic targets. Methods We used exome sequence data and electronic health …

INTRODUCTION Large-scale genetic studies of integrated health care populations, with
phenotypic data captured natively in the documentation of clinical care, have the potential to …

INTRODUCTION Familial hypercholesterolemia (FH) is a public health genomics priority but
remains underdiagnosed and undertreated despite widespread cholesterol screening. This …

Ten organizations within the Electronic Medical Records and Genomics Network developed
programs to implement pharmacogenomic sequencing and clinical decision support into …

… Penetrance is another factor that influenced our decision because we recognize that for
many genes, the associated risk is an overestimate because of ascertainment from families …

Chronic kidney disease (CKD) is a common complex condition associated with high
morbidity and mortality. Polygenic prediction could enhance CKD screening and prevention; …

Importance Detection of disease-associated variants in theBRCA1andBRCA2(BRCA1/2)
genes allows for cancer prevention and early diagnosis in high-risk individuals. Objectives To …

Importance Large-scale DNA sequencing identifies incidental rare variants in established
Mendelian disease genes, but the frequency of related clinical phenotypes in unselected …